A detailed history of Kensington Investment Counsel, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 2,041 shares of LLY stock, worth $1.62 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
2,041
Previous 2,061 0.97%
Holding current value
$1.62 Million
Previous $1.87 Million 3.06%
% of portfolio
0.76%
Previous 0.83%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$772.14 - $960.02 $15,442 - $19,200
-20 Reduced 0.97%
2,041 $1.81 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $7,973 - $9,999
-11 Reduced 0.53%
2,061 $1.87 Million
Q4 2023

Feb 15, 2024

SELL
$525.19 - $619.13 $54,619 - $64,389
-104 Reduced 4.78%
2,072 $1.21 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $54,772 - $75,511
126 Added 6.15%
2,176 $1.17 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $719,017 - $961,409
2,050 New
2,050 $961,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kensington Investment Counsel, LLC Portfolio

Follow Kensington Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.